Skip to main content
$300.19 $0.50 (0.2%)

04:00 PM EDT on 09/17/21

Biogen Inc (NASDAQ:BIIB)

CAPS Rating: 3 out of 5

The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies.

Current Price $300.19 Mkt Cap $44.7B
Open $300.85 P/E Ratio 23.90
Prev. Close $300.19 Div. (Yield) $0.00 (0.0%)
Daily Range $296.56 - $300.85 Volume 1,680,045
52-Wk Range $223.25 - $468.55 Avg. Daily Vol. 976,415

Caps

How do you think NASDAQ:BIIB will perform against the market?

Add Stock to CAPS Watchlist

All Players

964 Outperform
74 Underperform
 

All-Star Players

202 Outperform
11 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:BIIB Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

sojournerks (98.41)
Submitted October 27, 2018

Good company in promising sector

JorgeAura (25.76)
Submitted February 02, 2013

Nasdaq in maximums.

Recent Community Commentary

Read the most recent pitches from players about BIIB.

Recs

0
Member Avatar LeakyWallet (< 20) Submitted: 7/23/2021 5:29:22 PM : Underperform Start Price: $322.10 NASDAQ:BIIB Score: +7.76

Seems like the poor testing process control or outright fraud might be systemic within the company - kind of like the pharma version of Boeing MAX.

Recs

0
Member Avatar JohnnyCaffeine (41.00) Submitted: 7/21/2021 11:20:49 AM : Outperform Start Price: $326.32 NASDAQ:BIIB Score: -10.01

There are currently no other Alzheimer drug approvals on the radar. This highly-lucrative market will belong to Biogen for a long time.

Recs

0
Member Avatar rocker20 (23.01) Submitted: 12/8/2020 8:12:47 AM : Outperform Start Price: $246.30 NASDAQ:BIIB Score: +1.22

strong historical performer with good ROIC

Leaderboard

Find the members with the highest scoring picks in BIIB.

Score Leader

optioncoach

optioncoach (91.14) Score: +637.71

The Score Leader is the player with the highest score across all their picks in BIIB.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
fwhittlesey < 20 4/12/2007 Outperform 3Y $43.64 +585.33% +225.11% +360.22 1 Comment
tradersinsights 58.77 4/10/2007 Outperform 1Y $44.42 +573.30% +223.38% +349.92 1 Comment
anewday101 90.87 3/5/2007 Outperform 1Y $43.36 +589.76% +240.16% +349.60 0 Comment
ambina < 20 3/12/2007 Outperform NS $43.95 +580.50% +233.10% +347.40 0 Comment
mtung 39.37 3/8/2007 Outperform NS $44.10 +578.19% +233.82% +344.36 0 Comment
nickysone 51.21 4/9/2007 Outperform 3Y $44.86 +566.70% +223.07% +343.63 1 Comment
mgroeber < 20 4/9/2007 Outperform NS $44.86 +566.70% +223.07% +343.63 0 Comment
apple1jam 69.24 3/6/2007 2/27/2008 Outperform NS $43.94 +580.66% +238.06% +342.60 0 Comment
Actionman2go 64.46 4/13/2007 Outperform 3Y $45.00 +564.62% +222.72% +341.90 1 Comment
gliberty < 20 8/22/2006 Outperform 5Y $42.68 +600.75% +263.02% +337.73 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for BIIB.